All PlansCoverageLow impact
Prescribing Tips: Type 2 Diabetes — Drug Combinations To Avoid
EmblemHealth·Endocrinology, Family Medicine, Internal Medicine +1 more·Pharmacy
We identified it
Jun 20, 2026
Summary
EmblemHealth has updated their guidance on Type 2 diabetes medication combinations, reaffirming that concurrent use of GLP-1 and DPP-4 agents is not clinically effective. They have created an updated flyer to help providers make informed prescribing decisions and offer clinical pharmacist support for finding appropriate alternatives.
Action Required
Share the updated flyer 'Concurrent Use of GLP-1 and DPP-4 Agents' with providers who treat Type 2 diabetes patients. Contact EmblemHealth's clinical pharmacist at 718-938-2174 if assistance is needed finding clinically appropriate medication alternatives for members.